Podcast: Forecasting the Impact of Medicare Part D Drug Negotiations 8/31/23
4sight Health August 31, 2023
David Burda
Don’t know what to think about the regulatory and competitive implications of Medicare negotiating the prices of 10 drugs with pharmaceutical companies? We had some thoughts on the new episode of the 4sight Health Roundup podcast.
- David W. Johnson is CEO of 4sight Health.
- Julie Vaughan...
Topics: Biotechnology,
CMS,
Conferences / Podcast,
Congress / White House,
Govt Agencies,
HHS,
Insurance,
Medicare,
Patient / Consumer,
Pharma,
Pharma / Biotech,
Provider,
Trends Related Articles:
2023-08-31T20:22:39-04:00